0

Zydus Lifesciences gets USFDA nod to market chronic heart failure treatment drug – ET HealthWorld | Pharma

New Delhi: Zydus Lifesciences Ltd on Wednesday said it has received final approval from the Central Board of Direct Taxes (CBDT). US health regulators to market its generic sacubitril Valsartan Tablets This combination is used to treat chronic heart failure in adults.

The combination of sacubitril and valsartan is used to treat chronic heart failure in adults, helping to reduce the risk of death and hospitalization.

The company said that this medicine will be manufactured at the group’s formulation manufacturing plant located at Moraiya in Ahmedabad.

  • Published on July 10, 2024 at 06:23 PM IST

Join a community of 2M+ industry professionals

Subscribe to our newsletter to get the latest information and analysis.

Download ETHealthworld App

  • Get realtime updates
  • Save your favourite articles

icon g play - 2

icon app store - 4


Scan to download the app
health barcode - 6

zydus-lifesciences-gets-usfda-nod-to-market-chronic-heart-failure-treatment-drug-et-healthworld-pharma